Giloralimab (Anti-TNFRSF5 / CD40)
Giloralimab (Anti-TNFRSF5 / CD40) (A2884-GRP)
Products
Description
Giloralimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. MW: 145.26 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2884 |
| Target | CD markers |